Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_assertion description "[In familial cutaneous malignant melanoma (CMM), disruption of the retinoblastoma (pRB) pathway frequently occurs through inactivating mutations in the p16 (p16INK4A/CDKN2A/MTS1) gene or activating mutations in the G1-specific cyclin dependent kinase 4 gene (CDK4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_assertion evidence source_evidence_literature NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_assertion SIO_000772 10732752 NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_assertion wasDerivedFrom befree-20150227 NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_assertion wasGeneratedBy ECO_0000203 NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP677954.RA_6czs3Jm7n2vHAYK2DF89OLTNYqtcrkVw1Gz6EVlBuk130_provenance.